We are live on ! Find out more
MRVI icon

Maravai LifeSciences

158 hedge funds and large institutions have $344M invested in Maravai LifeSciences in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.08M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

1% less funds holding

Funds holding: 159158 (-1)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

6.28% less ownership

Funds ownership: 89.23%82.95% (-6.3%)

18% less capital invested

Capital invested by funds: $421M → $344M (-$77.2M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
158
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
1.94%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
28
Increased
51
Reduced
52
Closed
24
Calls
$1.29M
Puts
$1.08M
Net Calls
+$207K
Net Calls Change
-$3.15M
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
126
California State Teachers Retirement System (CalSTRS)
California
$16.7K -$2.76K -813 -12%
FFA
127
Farther Finance Advisors
California
$13.8K -$865 -255 -5%
SCM
128
Sterling Capital Management
North Carolina
$10.2K -$9.08K -2,679 -43%
GFM
129
GF Fund Management
China
$9.17K +$1.33K +392 +14%
HCA
130
Harbor Capital Advisors
Illinois
$9K +$3.9K +1,150 +60%
PLU
131
Performa Ltd (US)
South Carolina
$7.78K -$1.91K -564 -17%
Northwestern Mutual Wealth Management
132
Northwestern Mutual Wealth Management
Wisconsin
$7.08K +$8.48K +2,500 New
ASN
133
Advisory Services Network
Georgia
$7.03K +$8.42K +2,483 New
AF
134
Allworth Financial
California
$6.73K +$678 +200 +9%
Carson Wealth (CWM LLC)
135
Carson Wealth (CWM LLC)
Nebraska
$5.28K -$27 -8 -0.4%
C
136
Covestor
United Kingdom
$5K -$11.9K -3,522 -68%
QT
137
Quantbot Technologies
New York
$4.06K -$200K -58,887 -98%
Osaic Holdings
138
Osaic Holdings
Arizona
$3.22K -$115 -34 -3%
Bessemer Group
139
Bessemer Group
New Jersey
$3K
LSA
140
Leonteq Securities AG
Switzerland
$2.94K
US Bancorp
141
US Bancorp
Minnesota
$2.89K +$261 +77 +8%
Fifth Third Bancorp
142
Fifth Third Bancorp
Ohio
$2.5K +$3K +884 New
GI
143
GAMMA Investing
California
$2.35K +$2.33K +687 +474%
EWA
144
EverSource Wealth Advisors
Alabama
$2.32K +$85 +25 +3%
DWS
145
Dynamic Wealth Strategies
California
$2.29K
Optiver Holding
146
Optiver Holding
Netherlands
$2.23K +$705 +208 +36%
OCWP
147
Owl Creek Wealth Partners
Colorado
$2.21K +$2.64K +780 New
RIL
148
Rothschild Investment LLC
Illinois
$2.2K
Nisa Investment Advisors
149
Nisa Investment Advisors
Missouri
$1.8K
CIAM
150
Caitong International Asset Management
Hong Kong
$1.37K -$14.4K -4,234 -90%

MRVI Hedge Fund Activity: Q1 2026 in Review

158 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2026, worth a combined $344M — down 18% from $421M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MRVI positions and 24 closed out — a net gain of 4 holders — while 51 added to existing stakes and 52 trimmed.

The largest buyer was Braidwell, adding an estimated $6.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $18.1M.

  • 158 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2026, down from 159 in Q4 2025.
  • Funds reported $344M of Maravai LifeSciences stock for Q1 2026, down 18% quarter-over-quarter.
  • 28 funds opened new Maravai LifeSciences positions in Q1 2026 and 24 closed out, a net change of +4 holders.
  • The largest Maravai LifeSciences buyer in Q1 2026 was Braidwell, an estimated $6.4M added.
  • The largest Maravai LifeSciences seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q1 2026.